Showing results (121-130 of 127) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2011
SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axisJoseph P Ritchie, Vishnu C Ramani, Yongsheng Ren, et al.Blood|May 31, 2007
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapyYang Yang, Veronica MacLeod, Yuemeng Dai, et al.Journal of Medicinal Chemistry|February 5, 2010
Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growthKen D Johnstone, Tomislav Karoli, Ligong Liu, et al.Thrombosis Journal|November 30, 2022
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implicationsLorenzo Loffredo, Gianpaolo Vidili, Angela Sciacqua, et al.Nature Biotechnology|April 26, 2008
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical eventsMarco Guerrini, Daniela Beccati, Zachary Shriver, et al.Thrombosis and Haemostasis|February 5, 2024
Algorithm for Rapid Exclusion of Clinically Relevant Plasma Levels of Direct Oral Anticoagulants in Patients Using the DOAC Dipstick: An Expert Consensus PaperJob Harenberg, Robert C Gosselin, Adam Cuker, et al.Thrombosis and Haemostasis|June 25, 2021
The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus PaperGrigoris T Gerotziafas, Mariella Catalano, Yiannis Theodorou, et al.Pageof 13